Approximately 20–40% of patients with CRC preoperatively have increased systemic inflammation markers, such as neutrophil-to-lymphocyte ratio and modified Glasgow prognostic score based on C-reactive protein [36]. The gene discussed is CRP; the disease is colorectal carcinoma.